1-15 of 15
Julie M. Vose, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pralatrexate and Gemcitabine in Patients with Relapsed or Refractory Lymphoproliferative Malignancies: Phase 1 Results.

Steven M. Horwitz, MD, Julie M. Vose, M.D., Ranjana Advani, MD, Kamalesh Sankhala, MD, Swaminathan Padmanabhan, MD, Paul A. Hamlin, Jr., MD, Andy Chen, MD, PhD, Jasmine M Zain, MD, Steven Fruchtman, MD, Owen A O'Connor, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1674.
https://doi.org/10.1182/blood.V114.22.1674.1674
Published: 2009
Journal Articles

Durable Responses After Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory (R/R) Aggressive Non-Hodgkin's Lymphoma (a-NHL): Results From An International Phase 2 Study (CC-5013-NHL-003).

Thomas E Witzig, MD, Julie M. Vose, M.D., Pier Luigi Zinzani, MD, Craig B. Reeder, MD, Rena Buckstein, MD, FRCPC, Jonathan Polikoff, MD, Pingshan Guo, Dennis Pietronigro, Annette Ervin-Haynes, Myron S Czuczman
Journal: Blood
Blood (2009) 114 (22): 1676.
https://doi.org/10.1182/blood.V114.22.1676.1676
Published: 2009
Journal Articles

Phase I Analysis of the Safety and Pharmacodynamics of the Novel Broad Spectrum Histone Deacetylase Inhibitor (HDACi) PCI-24781 in Relapsed and Refractory Lymphoma.

Andrew M Evens, DO, MSc, Weiyun Ai, MD, PhD, Sriram Balasubramanian, PhD, Mint Sirisawad, M.S., Chitra Mani, PhD, Martha Guerra, RN, Nancy Szakacs, BS, MBA, David Loury, PhD, Joseph J Buggy, Ph.D., Ahmed Hamdy, MD, Julie M. Vose, M.D., Nancy L Bartlett, MD
Journal: Blood
Blood (2009) 114 (22): 2726.
https://doi.org/10.1182/blood.V114.22.2726.2726
Published: 2009
Journal Articles

Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.

Malik E. Juweid, MD, Sergei I. Syrbu, Michelle Bleile, Andreas Buck, Marielle Wondergem, MD, Julie M. Vose, M.D.
Journal: Blood
Blood (2009) 114 (22): 3236.
https://doi.org/10.1182/blood.V114.22.3236.3236
Published: 2009
Journal Articles

Single-Agent Lenalidomide for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma Who Had Received Prior Stem Cell Transplant.

Julie M. Vose, M.D., Thomas Habermann, Myron S Czuczman, Pier Luigi Zinzani, Craig B. Reeder, MD, Joseph Tuscano, MD, Izidore S Lossos, MD, Dennis Pietronigro, Annette Ervin-Haynes, Thomas Witzig
Journal: Blood
Blood (2009) 114 (22): 2699.
https://doi.org/10.1182/blood.V114.22.2699.2699
Published: 2009
Journal Articles

A Phase I Study of PRO131921, a Novel Anti-CD20 Monoclonal Antibody in Patients with Relapsed/Refractory CD20 + Indolent NHL: Correlation Between Clinical Responses and AUC Pharmacokinetics.

Jonathan W. Friedberg, MD, Julie M. Vose, M.D., Brad S Kahl, MD, Mark W. Brunvand, MD, Andre Goy, MD, Yvette L. Kasamon, Bart Burington, Ph.D, Jing Li, PhD, William Ho, MD, PhD, Bruce D. Cheson, MD
Journal: Blood
Blood (2009) 114 (22): 3742.
https://doi.org/10.1182/blood.V114.22.3742.3742
Published: 2009
Journal Articles

Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.

Marta Scandurra, Michael Mian, MD, Cassio P. De Campos, Paola M.V. Rancoita, Timothy C. Greiner, MS, MD, Wing C. Chan, Julie M. Vose, M.D., Giorgio Inghirami, Annalisa Chiappella, Luca Baldini, Maurilio Ponzoni, Andres JM Ferreri, Santiago Montes Moreno, Miguel A. Piris, MD, Silvia Franceschetti, Gianluca Gaidano, MD, Fabio Facchetti, Alessandra Tucci, Thierry Lazure, Olivier Lambotte, Silvia Uccella, Maria Grazia Tibiletti, Graziella Pinotti, Giancarlo Pruneri, Giovanni Martinelli, Josep F. Nomdedeu, MD, Ekaterina Chigrinova, MD, Andrea Rinaldi, Emanuele Zucca, Ivo Kwee, Francesco Bertoni, MD
Journal: Blood
Blood (2009) 114 (22): 3957.
https://doi.org/10.1182/blood.V114.22.3957.3957
Published: 2009
Journal Articles

Clinicopathologic Characteristics of HIV-Associated Peripheral T-Cell Lymphoma.

Jorge Castillo, MD, Brady Beltran, MD, Jaime Collins, MD, Jose L Diez-Martin, MD, Francisco Hernandez-Ilizaliturri, MD, Steven M. Horwitz, MD, Julie M. Vose, M.D.
Journal: Blood
Blood (2009) 114 (22): 3924.
https://doi.org/10.1182/blood.V114.22.3924.3924
Published: 2009
Journal Articles

Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial.

Jonathan W. Friedberg, MD, Julie M. Vose, M.D., Jennifer L Kelly, PhDMPH, Faith Young, MD, Jane Liesveld, MD, James O. Armitage, M.D., Nicole Proia, MPH, Kim Cruttenden, N.P., John P. Leonard, MD
Journal: Blood
Blood (2009) 114 (22): 924.
https://doi.org/10.1182/blood.V114.22.924.924
Published: 2009
Journal Articles

Association of Follow-up Care Characteristics and Outcomes According to Number of Follow-up Providers Among Survivors of Hematologic Malignancies.

Anthony J. Cannon, B.S., Deborah L. Darrington, M.D., Linda K. Bauer, B.S., James O. Armitage, M.D., Julie M. Vose, M.D., Fausto R. Loberiza, Jr., M.D., M.S.
Journal: Blood
Blood (2009) 114 (22): 1375.
https://doi.org/10.1182/blood.V114.22.1375.1375
Published: 2009
Journal Articles

Characterization and Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Isolated from Liver and Kidney

Ganapati V. Hegde, Ph.D., Tara M. Nordgren, B.S., Corey M. Munger, Ph.D., Amit K. Mittal, D.V.M., Philip J. Bierman, M.D., Dennis D. Weisenburger, M.D., Graham Sharp, Ph.D., Julie M. Vose, M.D., Shantaram Joshi, PhD
Journal: Blood
Blood (2008) 112 (11): 2622.
https://doi.org/10.1182/blood.V112.11.2622.2622
Published: 2008
Journal Articles

Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy.

Shantaram S. Joshi, PhD, Corey M. Munger, Ph.D., Ganapati V. Hegde, Ph.D., Dennis D. Weisenburger, M.D., Julie M. Vose, M.D.
Journal: Blood
Blood (2007) 110 (11): 2760.
https://doi.org/10.1182/blood.V110.11.2760.2760
Published: 2007
Journal Articles

Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Clinicopathologic Study of 340 Cases from the International T-Cell Lymphoma Project.

Dennis D. Weisenburger, MD, Wyndham H. Wilson, M.D., Julie M. Vose, M.D.
Journal: Blood
Blood (2006) 108 (11): 2458.
https://doi.org/10.1182/blood.V108.11.2458.2458
Published: 2006
Journal Articles

Sonic Hedgehog Signaling in Mantle Cell Lymphoma.

Ganapati V. Hegde, PhD, Katy Emanuel, Avadhut D. Joshi, Corey M. Munger, Dennis D. Weisenburger, M.D., Julie M. Vose, M.D., Shantaram S. Joshi, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2046.
https://doi.org/10.1182/blood.V108.11.2046.2046
Published: 2006
Journal Articles

Fc-Gamma Receptor IIIa and Interferon-Gamma SNPs Do Not Predict Responsiveness of Follicular Lymphoma to Galiximab (Anti-CD80 Antibody).

Myron Czuczman, M.D., Bryan R. Leigh, M.D., Thomas E. Witzig, M.D., Julie M. Vose, M.D., Anas Younes, M.D., Baha Alkuzweny, Ph.D., Anne Larocca, Ph.D., Xianjun Cao, M.S., Aron Thall, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3292.
https://doi.org/10.1182/blood.V104.11.3292.3292
Published: 2004